UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Xylo10-Adr5-InjSol-SE-AJ-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100001718-00008318, http://ema.europa.eu/fhir/eurdId
/1233
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Solution for injection
indication:
Infiltrationsanestesi, perifera nervblockader, terapeutiska och diagnostiska blockader, epiduralanestesi. Xylocain adrenalin är avsett för vuxna och barn över 1 år.
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: lidocaine, combinations
name
productName: Xylocain adrenalin 10 mg/ml + 5 mikrogram/ml Injektionsvätska, lösning
part
part: Xylocain adrenalin
type: Invented Name Part
part
part: 10 mg/ml + 5 mikrogram/ml
type: Strength part
part
part: Injektionsvätska, lösning
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish